PHYSICIAN AND PATIENT PERCEPTIONS REGARDING CARE TRANSITIONS, ORAL ANTICOAGULANT TREATMENT AND MANAGEMENT OF NON-VALVULAR ATRIAL FIBRILLATION

被引：0
|
作者：
Stephenson, J. [1 ]
Franchino-Elder, J. [2 ]
Zhang, X. [1 ]
Tan, H. [3 ]
Kraft, E. [4 ]
Wang, C. [2 ]
Willey, V [1 ]
机构：
[1] HealthCore Inc, Wilmington, DE USA
[2] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT USA
[3] HealthCore Inc, San Diego, CA USA
[4] Anthem, Denver, CO USA
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
10.1016/j.jval.2019.04.520
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV84
引用
收藏
页码：S134 / S134
页数：1
相关论文
共 50 条
  • [41] Impact of direct oral anticoagulant use on mortality in very old patients with non-valvular atrial fibrillation
    Takahashi, Masahiko
    Okawa, Keisuke
    Morimoto, Takeshi
    Tsushima, Ryu
    Sudo, Yuya
    Sakamoto, Ai
    Sogo, Masahiro
    Ozaki, Masatomo
    Doi, Masayuki
    Morita, Hiroshi
    Okumura, Ken
    Ito, Hiroshi
    AGE AND AGEING, 2022, 51 (07)
  • [42] Anticoagulant treatment in patients with non-valvular atrial fibrillation and chronic anemia: still gray areas
    Alboni, Paolo
    Stucci, Nicola
    Messop, Anny Carole
    GIORNALE ITALIANO DI CARDIOLOGIA, 2021, 22 (04) : 311 - 318
  • [43] DIRECT ORAL ANTICOAGULANT EDOXABAN IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION: RESULTS OF DIRECT COMPARISON WITH WARFARIN
    Yavelov, I. S.
    KARDIOLOGIYA, 2020, 60 (08) : 124 - 129
  • [44] Prescribers' perceptions of benefits and limitations of direct acting oral anticoagulants in non-valvular atrial fibrillation
    Generalova, Daria
    Cunningham, Scott
    Leslie, Stephen J.
    Rushworth, Gordon F.
    Mciver, Laura
    Stewart, Derek
    PHARMACY PRACTICE-GRANADA, 2020, 18 (02): : 1 - 6
  • [45] Initiation and continuation of oral anticoagulant prescriptions for stroke prevention in non-valvular atrial fibrillation: A cohort study in primary care in France
    Collings, Shuk-Li
    Vannier-Moreau, Virginie
    Johnson, Michelle E.
    Stynes, Gillian
    Lefevre, Cinira
    Maguire, Andrew
    Asmar, Joelle
    Bizouard, Geoffray
    Duhot, Didier
    Mouquet, Frederic
    Fauchier, Laurent
    ARCHIVES OF CARDIOVASCULAR DISEASES, 2018, 111 (05) : 370 - 379
  • [46] Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
    Amol D Dhamane
    Inmaculada Hernandez
    Manuela Di Fusco
    Cynthia Gutierrez
    Mauricio Ferri
    Cristina Russ
    Wan-Lun Tsai
    Birol Emir
    Huseyin Yuce
    Allison Keshishian
    American Journal of Cardiovascular Drugs, 2022, 22 : 333 - 343
  • [47] Non-persistence to Oral Anticoagulation Treatment in Patients with Non-valvular Atrial Fibrillation in the USA
    Dhamane, Amol D.
    Hernandez, Inmaculada
    Di Fusco, Manuela
    Gutierrez, Cynthia
    Ferri, Mauricio
    Russ, Cristina
    Tsai, Wan-Lun
    Emir, Birol
    Yuce, Huseyin
    Keshishian, Allison
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2022, 22 (03) : 333 - 343
  • [48] Psychological effects of treatment with novel oral anticoagulants in non-valvular atrial fibrillation patients
    Oncel, Can Ramazan
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2016, 16 (05): : 364 - 364
  • [49] Safety of New Anticoagulant Treatments in Swedish Patients with Non-valvular Atrial Fibrillation
    Nyman, Anastasia
    Collin, Julius J. K. M.
    Borg, Natalia
    Gry, Marcus
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 405 - 405
  • [50] Geographic and Racial Variation in Oral Anticoagulant Treatment Among Commercially Insured Patients With Non-Valvular Atrial Fibrillation in the United States
    Atwater, Brett D.
    Singh, Risho
    Parmar, Shashi
    Ogbonnaya, Augustina
    Kang, Amiee
    Russ, Cristina
    Cheng, Dong
    Hagan, Melissa
    Deeba, Serina
    Hines, Dionne M.
    Atreja, Nipun
    CIRCULATION, 2023, 148
12345